Aesku NY Overview
- Latest Deal Type
Aesku NY General Information
Developer of a screening technology intended for connective tissue disorders such as lupus. The company provides test methods for the detection of autoantibodies for connective tissue and other autoimmune disorders, enabling clinicians to detect patients with diseases and provide treatments accordingly.
Privately Held (backing)
Other Healthcare Services
- Buffalo, NY
- United States
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Aesku NY Valuation & Funding
|Deal Type||Date||Amount||Raised to Date||Post-Val||Status||Stage|
|2. Accelerator/Incubator||05-Jun-2014||Completed||Generating Revenue|
|1. Spin-Off||01-Jan-2003||Completed||Generating Revenue|
Aesku NY Executive Team (1)
|Name||Title||Board Seat||Contact Info|
|Vijay Kumar Ph.D||Vice President & Chief Operating Officer|
Aesku NY Signals
Aesku NY Investors (1)
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|
|Start-up NY||Accelerator/Incubator||000 0000||000000 0|